Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Heterozygous | Phase3 | Argentina Austria Belgium Brazil China Czechia France Germany Greece Hong Kong Hungary Israel Italy Malaysia Netherlands Poland Portugal South Africa Spain Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT06597019 |
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Argentina Canada China Czechia France Germany Hungary Italy Japan Netherlands Poland Slovakia South Korea Spain Taiwan United Kingdom United States View all |
NCT06947993 |
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | France Germany Italy Japan Spain Turkey (Türkiye) United Kingdom View all |
NCT05935215 |
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | South Korea | NCT05274425 | |
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). |
Juvenile Psoriatic Arthritis | Phase1 | United States | NCT06751238 |
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 | Argentina Austria Belgium Brazil China Colombia France Germany Greece Hungary India Italy Japan Malaysia Mexico Poland Portugal South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT06470048 |
Post Marketing Study on Pluvicto in Korea |
Metastatic Castration-resistant Prostate Cancer | South Korea | NCT06514521 | |
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA |
ANCA Associated Vasculitis (AAV) | Phase2 | Brazil Israel Japan Saudi Arabia Singapore Switzerland United Kingdom United States View all |
NCT06868290 |
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase2 | Austria Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Portugal Spain Switzerland United Kingdom United States View all |
NCT05646381 |
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer |
Breast Cancer | Jordan Oman Saudi Arabia United Arab Emirates View all |
NCT06075758 |